- Home
- AFG vs PCVX Comparison
AFG vs PCVX Comparison
Compare AFG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFG
- PCVX
- Stock Information
- Founded
- AFG 1872
- PCVX 2013
- Country
- AFG United States
- PCVX United States
- Employees
- AFG N/A
- PCVX N/A
- Industry
- AFG Property-Casualty Insurers
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- AFG Finance
- PCVX Health Care
- Exchange
- AFG Nasdaq
- PCVX Nasdaq
- Market Cap
- AFG 11.4B
- PCVX 9.4B
- IPO Year
- AFG N/A
- PCVX 2020
- Fundamental
- Price
- AFG $127.15
- PCVX $71.18
- Analyst Decision
- AFG Hold
- PCVX Strong Buy
- Analyst Count
- AFG 5
- PCVX 9
- Target Price
- AFG $143.80
- PCVX $147.50
- AVG Volume (30 Days)
- AFG 570.1K
- PCVX 1.2M
- Earning Date
- AFG 04-30-2025
- PCVX 02-25-2025
- Dividend Yield
- AFG 6.54%
- PCVX N/A
- EPS Growth
- AFG 5.17
- PCVX N/A
- EPS
- AFG 10.57
- PCVX N/A
- Revenue
- AFG $8,010,000,000.00
- PCVX N/A
- Revenue This Year
- AFG N/A
- PCVX N/A
- Revenue Next Year
- AFG $5.86
- PCVX N/A
- P/E Ratio
- AFG $12.03
- PCVX N/A
- Revenue Growth
- AFG 7.49
- PCVX N/A
- 52 Week Low
- AFG $118.97
- PCVX $58.10
- 52 Week High
- AFG $150.19
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- AFG 49.63
- PCVX 33.42
- Support Level
- AFG $124.66
- PCVX $69.38
- Resistance Level
- AFG $128.98
- PCVX $76.38
- Average True Range (ATR)
- AFG 2.40
- PCVX 3.78
- MACD
- AFG 0.95
- PCVX -0.72
- Stochastic Oscillator
- AFG 80.98
- PCVX 11.39
About AFG American Financial Group Inc.
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The company also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. The company's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.